通过患者组织传播药物不良反应信息:荷兰试点研究经验
该试点研究探索如何通过患者组织传播药物不良反应信息,以左甲状腺素与惊恐发作信号为例,经荷兰甲状腺组织数字通讯、社交媒体、网站和印刷杂志发布。数字通讯触达约5000名订阅者,Facebook上13,820人查看、2,346次点击,互动积极且尊重。结论认为患者组织可帮助将药物不良反应有效传达给相关受众,社交媒体帖子互动强于该组织其他通讯,评论中分享的患者体验进一步强化了原始信号。
要点
- 患者组织可作为药物不良反应信息触达患者的有效渠道。
- 经患者组织社交媒体发布的药物不良反应信息互动积极且受众兴趣强。
- 社交媒体评论中的患者体验可强化原始药物不良反应信号。
核心结论
- 患者组织能够帮助将药物不良反应信息有效传达给相关受众。
研究设计与样本
- 试点研究,将左甲状腺素与惊恐发作的信号按患者需求调整语言、风格和内容后,经荷兰甲状腺组织数字通讯、社交媒体、网站和印刷杂志传播。
主要发现
- 数字通讯分发至约5000名订阅者。
- Facebook上13,820人查看消息,消息内2,346次点击,提示有意阅读整篇帖子。
- 社交媒体互动积极且语气尊重。
- 社交媒体帖子比该患者组织其他通讯产生更多互动,表明对该信息兴趣强烈。
- 社交媒体评论中分享的额外患者体验进一步强化了原始信号及其与患者的相关性,形成反馈循环。
临床怎么用
- 可与患者组织合作,将药物不良反应信号按患者需求调整后通过其数字通讯、社交媒体、网站和印刷杂志传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. It is not enough to disseminate such findings through regulatory and scientific channels; targeted efforts to reach patients are necessary. One possible avenue is to collaborate with patient organizations. OBJECTIVES: The aim of this pilot study was to explore how adverse drug reactions can be communicated through patient organizations. METHODS: A text describing a signal of levothyroxine and panic attacks was tailored to patients' needs, in terms of language, style and content, with emphasis placed on what to do when experiencing the symptoms described. The signal was communicated via the Dutch thyroid organization's digital newsletter, social media channels, website and print magazine. RESULTS: The digital newsletter was distributed to around 5000 subscribers. On Facebook, 13,820 people viewed the message, with 2346 clicks in the message, indicating an intention to read the whole post. The interactions on social media were positive, and the tone was respectful. CONCLUSION: Patient organizations can help enable effective communication of adverse drug reactions to a relevant audience. The social media post generated more engagement than other communications from the patient organization, indicating a strong interest in this information. The additional patient experiences that were shared in the comments on social media further strengthened the original signal and its relevance to patients, creating an interesting feedback loop. The favourable experiences in this study support further consideration and exploration of this approach to communicate adverse drug reactions to patients.
引用
- Härmark L, Weits G, Meijer R, et al. Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands. Drug Saf. 2020. PMID: 32418193. doi:10.1007/s40264-020-00932-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。